Insight Molecular Diagnostics (IMDX) Income from Discontinued Operations (2022 - 2023)

Insight Molecular Diagnostics (IMDX) Income from Discontinued Operations (2022 - 2023) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Income (Discontinued) (Qtr)
1	Thermo Fisher Scientific	234.15 Bn	230.09 Bn	8.34 Bn	-
2	Danaher	152.10 Bn	147.75 Bn	3.61 Bn	-
3	Natera	48.48 Bn	47.38 Bn	486.15 Mn	-
4	Agilent Technologies	44.35 Bn	42.55 Bn	990.00 Mn	-
5	Iqvia Holdings	43.68 Bn	41.60 Bn	1.44 Bn	-
6	Idexx Laboratories	43.02 Bn	42.83 Bn	779.09 Mn	-
7	Illumina	34.39 Bn	33.22 Bn	770.00 Mn	-
8	Mettler Toledo International	28.29 Bn	28.24 Bn	650.22 Mn	-
9	Labcorp Holdings	27.51 Bn	27.37 Bn	1.11 Bn	-
10	Insight Molecular Diagnostics	158.03 Mn	139.50 Mn	157,000.00	-

Download Data